Progressive Disease with Mixed Response After Immunotherapy in Non-Small Cell Lung Cancer.
Juncai LvWeiwei YanRan ZhangXi ChenZiyuan RenDawei ChenJin-Ming YuPublished in: Journal of inflammation research (2024)
PDMR was primarily observed in stage IV patients and previously irradiated patients. OS and PFS were inferior in patients with PDMR compared to patients with PDNMR. The continuation of immunotherapy in PDMR patients could extend their survival.